Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.
作者信息
Drexler H
机构信息
Medizinische Klinik III, University of Freiburg, Germany.
出版信息
Br Heart J. 1994 Sep;72(3 Suppl):S11-4. doi: 10.1136/hrt.72.3_suppl.s11.
Abstract
摘要
相似文献
1
Endothelial dysfunction in heart failure and potential for reversal by ACE inhibition.心力衰竭中的内皮功能障碍及血管紧张素转换酶抑制逆转的可能性。
Br Heart J. 1994 Sep;72(3 Suppl):S11-4. doi: 10.1136/hrt.72.3_suppl.s11.
2
Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.血管紧张素转换酶抑制对慢性心力衰竭患者内皮功能障碍的影响。
Eur Heart J. 1998 Jul;19 Suppl G:G48-53.
3
Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure.
Am J Cardiol. 1995 Nov 24;76(15):13E-18E.
4
Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther. 1998 Jan;24(1):38.
5
Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.血管紧张素转换酶抑制期间影响血管紧张素代谢的多种因素：来自分子生物学和遗传学研究的见解
Br Heart J. 1994 Sep;72(3 Suppl):S3-10. doi: 10.1136/hrt.72.3_suppl.s3.
6
Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.血管紧张素转换酶抑制与内皮素拮抗用于心力衰竭内皮功能障碍：单一治疗或联合治疗
J Cardiovasc Pharmacol. 2002 Oct;40(4):594-600. doi: 10.1097/00005344-200210000-00013.
7
Endothelial function and dysfunction in heart failure.心力衰竭中的内皮功能与功能障碍
Eur Heart J. 1998 Jul;19 Suppl G:G41-7.
8
[Endothelial dysfunction in cardial failure: potential mechanisms].
Arch Mal Coeur Vaiss. 1997 Nov;90 Spec No 6:29-34.
9
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.用 ACE 抑制剂进行 CAD 的二级预防：内皮细胞的生死较量。
Cardiovasc Drugs Ther. 2010 Aug;24(4):331-9. doi: 10.1007/s10557-010-6244-x.
10
Interactions among ACE, kinins and NO.
Cardiovasc Res. 1999 Aug 15;43(3):549-61. doi: 10.1016/s0008-6363(99)00091-7.
引用本文的文献
1
Valsartan in the treatment of heart attack survivors.缬沙坦用于治疗心脏病发作幸存者。
Vasc Health Risk Manag. 2006;2(2):125-38. doi: 10.2147/vhrm.2006.2.2.125.
2
Endothelin in congestive heart failure.
Basic Res Cardiol. 1996;91 Suppl 1:21-9. doi: 10.1007/BF00810520.
本文引用的文献
1
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.内皮素-1在肺动脉高压患者肺组织中的表达。
N Engl J Med. 1993 Jun 17;328(24):1732-9. doi: 10.1056/NEJM199306173282402.
2
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.充血性心力衰竭患者乙酰胆碱介导的血管舒张功能受损。内皮源性血管舒张因子和血管收缩因子的作用。
Circulation. 1993 Jul;88(1):55-61. doi: 10.1161/01.cir.88.1.55.
3
Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure.
J Am Coll Cardiol. 1993 Aug;22(2):615-20. doi: 10.1016/0735-1097(93)90073-a.
4
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.慢性血管紧张素转换酶抑制与血管紧张素II 1型受体阻断对大鼠心肌梗死后心脏重塑的比较作用
Circulation. 1994 May;89(5):2273-82. doi: 10.1161/01.cir.89.5.2273.
5
A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure.正常受试者与充血性心力衰竭患者中血管扩张剂刺激对周围阻力血管影响的比较。
J Clin Invest. 1968 Apr;47(4):960-70. doi: 10.1172/JCI105788.
6
A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure.正常受试者和充血性心力衰竭患者在动态前臂运动期间局部血流与氧利用的比较。
Circulation. 1974 Jul;50(1):137-43. doi: 10.1161/01.cir.50.1.137.
7
Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure.严重心力衰竭患者在单腿运动与双腿运动时，肢体最大血流量未能增加。
Circulation. 1986 Aug;74(2):245-51. doi: 10.1161/01.cir.74.2.245.
8
Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone.
Circulation. 1987 Dec;76(6):1344-52. doi: 10.1161/01.cir.76.6.1344.
9
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.一氧化氮的释放构成了内皮源性舒张因子的生物活性。
Nature. 1987;327(6122):524-6. doi: 10.1038/327524a0.
10
Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease.
Am J Cardiol. 1987 Jul 1;60(1):107-11. doi: 10.1016/0002-9149(87)90995-7.
Zotero 插件